Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal

Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison

(2016) Elyse Swallow et al.   CLINICAL THERAPEUTICS

New methods for treatment effect calibration, with applications to non-inferiority trials

(2015) Zhiwei Zhang et al.   BIOMETRICS

Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension

(2015) Howard HZ Thom et al.   BMC Medical Research Methodology

Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology

(2015) Suzy Van Sanden et al.   CURRENT MEDICAL RESEARCH AND OPINION

From sample average treatment effect to population average treatment effect on the treated: combining experimental with observational studies to estimate population treatment effects

(2015) Erin Hartman et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Simulation and Matching-Based Approaches for Indirect Comparison of Treatments

(2015) K. Jack Ishak et al.   PHARMACOECONOMICS

Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic)

(2015) M. Belger et al.   VALUE IN HEALTH

Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

(2014) Jeroen P. Jansen et al.   VALUE IN HEALTH

Likelihood reweighting methods to reduce potential bias in noninferiority trials which rely on historical data to make inference

(2013) Lei Nie et al.   Annals of Applied Statistics

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

(2013) Vanja Sikirica et al.   CNS DRUGS

An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma – a flawed analysis and a problematic response

(2013) David C Hoaglin   EXPERT OPINION ON PHARMACOTHERAPY

Prognosis research strategy (PROGRESS) 4: Stratified medicine research

(2013) A. D. Hingorani et al.   BMJ-British Medical Journal

An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma – a flawed analysis?

(2012) David C Hoaglin et al.   EXPERT OPINION ON PHARMACOTHERAPY

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials

(2012) Sarah Donegan et al.   STATISTICS IN MEDICINE

Mixed treatment comparisons using aggregate and individual participant level data

(2012) Pedro Saramago et al.   STATISTICS IN MEDICINE

Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research

(2012) James E. Signorovitch et al.   VALUE IN HEALTH

Network meta-analysis of individual and aggregate level data

(2012) Jeroen P. Jansen   Research Synthesis Methods

Selecting the best scale for measuring treatment effect in a network meta-analysis: a case study in childhood nocturnal enuresis

(2012) Deborah M. Caldwell et al.   Research Synthesis Methods

Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials

(2011) James E. Signorovitch et al.   CURRENT MEDICAL RESEARCH AND OPINION

An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples

(2011) Giuseppe Di Lorenzo et al.   EXPERT OPINION ON PHARMACOTHERAPY

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

(2011) David C. Hoaglin et al.   VALUE IN HEALTH

Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial

(2010) S. R. Cole et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The use of propensity scores to assess the generalizability of results from randomized trials

(2010) Elizabeth A. Stuart et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

No Head-to-Head Trial? Simulate the Missing Arms

(2010) J. Jaime Caro et al.   PHARMACOECONOMICS

Comparative Effectiveness Without Head-to-Head Trials

(2010) James E. Signorovitch et al.   PHARMACOECONOMICS

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

Covariate-Adjusted Putative Placebo Analysis in Active-Controlled Clinical Trials

(2009) Zhiwei Zhang   Statistics in Biopharmaceutical Research

Misunderstandings between experimentalists and observationalists about causal inference

(2008) Kosuke Imai et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

On effect‐measure modification: Relationships among changes in the relative risk, odds ratio, and risk difference

(2008) Babette Brumback et al.   STATISTICS IN MEDICINE